Operating Income (Loss) of INFINITY PHARMACEUTICALS, INC. from 30 Jun 2010 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- The net result for the period of deducting operating expenses from operating revenues.
- Summary
-
INFINITY PHARMACEUTICALS, INC. quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Jun 2010 to 30 Jun 2023.
- INFINITY PHARMACEUTICALS, INC. Operating Income (Loss) for the quarter ending 30 Jun 2023 was $10,120,000, a 16% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. Operating Income (Loss) for the twelve months ending 30 Jun 2023 was $42,046,000, a 9.9% increase year-over-year.
- INFINITY PHARMACEUTICALS, INC. annual Operating Income (Loss) for 2022 was $44,844,000, a 0.53% increase from 2021.
- INFINITY PHARMACEUTICALS, INC. annual Operating Income (Loss) for 2021 was $45,083,000, a 17% decline from 2020.
- INFINITY PHARMACEUTICALS, INC. annual Operating Income (Loss) for 2020 was $38,497,000, a 16% increase from 2019.
- Source SEC data
- View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)
INFINITY PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $42,046,000 | $10,120,000 | +$1,898,000 | +16% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $43,944,000 | $11,507,000 | +$900,000 | +7.3% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | $44,844,000 | $9,538,000 | +$1,962,000 | +17% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2022 | $46,806,000 | $10,881,000 | -$131,000 | -1.2% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $46,675,000 | $12,018,000 | -$767,000 | -6.8% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 |
| Q1 2022 | $45,908,000 | $12,407,000 | -$825,000 | -7.1% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2021 | $45,083,000 | $11,500,000 | -$1,267,000 | -12% | 01 Oct 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| Q3 2021 | $43,816,000 | $10,750,000 | -$1,905,000 | -22% | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 14 Nov 2022 | 2022 | Q3 |
| Q2 2021 | $41,911,000 | $11,251,000 | -$2,332,000 | -26% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2021 | $39,579,000 | $11,582,000 | -$1,082,000 | -10% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 03 May 2022 | 2022 | Q1 |
| Q4 2020 | $38,497,000 | $10,233,000 | +$1,322,000 | +11% | 01 Oct 2020 | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| Q3 2020 | $39,819,000 | $8,845,000 | +$1,736,000 | +16% | 01 Jul 2020 | 30 Sep 2020 | 10-Q | 02 Nov 2021 | 2021 | Q3 |
| Q2 2020 | $41,555,000 | $8,919,000 | +$826,000 | +8.5% | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 27 Jul 2021 | 2021 | Q2 |
| Q1 2020 | $42,381,000 | $10,500,000 | +$3,283,000 | +24% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 13 May 2021 | 2021 | Q1 |
| Q4 2019 | $45,664,000 | $11,555,000 | -$3,099,000 | -37% | 01 Oct 2019 | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY |
| Q3 2019 | $42,565,000 | $10,581,000 | -$23,760,000 | -180% | 01 Jul 2019 | 30 Sep 2019 | 10-Q | 09 Nov 2020 | 2020 | Q3 |
| Q2 2019 | $18,805,000 | $9,745,000 | -$2,610,000 | -37% | 01 Apr 2019 | 30 Jun 2019 | 10-Q | 30 Jul 2020 | 2020 | Q2 |
| Q1 2019 | $16,195,000 | $13,783,000 | -$4,266,000 | -45% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 11 May 2020 | 2020 | Q1 |
| Q4 2018 | $11,929,000 | $8,456,000 | -$436,000 | -5.4% | 01 Oct 2018 | 31 Dec 2018 | 10-K | 03 Mar 2020 | 2019 | FY |
| Q3 2018 | $11,493,000 | $13,179,000 | +$21,022,000 | 01 Jul 2018 | 30 Sep 2018 | 10-Q | 30 Oct 2019 | 2019 | Q3 | |
| Q2 2018 | $32,515,000 | $7,135,000 | +$2,971,000 | +29% | 01 Apr 2018 | 30 Jun 2018 | 10-Q | 30 Jul 2019 | 2019 | Q2 |
| Q1 2018 | $35,486,000 | $9,517,000 | +$959,000 | +9.2% | 01 Jan 2018 | 31 Mar 2018 | 10-Q | 07 May 2019 | 2019 | Q1 |
| Q4 2017 | $36,445,000 | $8,020,000 | +$15,213,000 | +65% | 01 Oct 2017 | 31 Dec 2017 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2017 | $51,658,000 | $7,843,000 | +$12,091,000 | +61% | 01 Jul 2017 | 30 Sep 2017 | 10-Q | 05 Nov 2018 | 2018 | Q3 |
| Q2 2017 | $63,749,000 | $10,106,000 | -$63,150,000 | -119% | 01 Apr 2017 | 30 Jun 2017 | 10-Q | 07 Aug 2018 | 2018 | Q2 |
| Q1 2017 | $599,000 | $10,476,000 | +$30,292,000 | +74% | 01 Jan 2017 | 31 Mar 2017 | 10-Q | 08 May 2018 | 2018 | Q1 |
| Q4 2016 | $30,891,000 | $23,233,000 | +$15,928,000 | +41% | 01 Oct 2016 | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q3 2016 | $46,819,000 | $19,934,000 | -$63,194,000 | -146% | 01 Jul 2016 | 30 Sep 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q2 2016 | $16,375,000 | $53,044,000 | +$91,636,000 | 01 Apr 2016 | 30 Jun 2016 | 10-K | 15 Mar 2018 | 2017 | FY | |
| Q1 2016 | $75,261,000 | $40,768,000 | +$51,847,000 | +56% | 01 Jan 2016 | 31 Mar 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| Q4 2015 | $127,108,000 | $39,161,000 | -$53,000 | -0.14% | 01 Oct 2015 | 31 Dec 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q3 2015 | $127,055,000 | $43,260,000 | -$64,442,000 | -60% | 01 Jul 2015 | 30 Sep 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q2 2015 | $62,613,000 | $38,592,000 | -$3,370,000 | -9.6% | 01 Apr 2015 | 30 Jun 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q1 2015 | $59,243,000 | $92,615,000 | -$51,320,000 | -124% | 01 Jan 2015 | 31 Mar 2015 | 10-K | 14 Mar 2017 | 2016 | FY |
| Q4 2014 | $7,923,000 | $39,108,000 | -$6,024,000 | -18% | 01 Oct 2014 | 31 Dec 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q3 2014 | $1,899,000 | $107,702,000 | +$141,878,000 | 01 Jul 2014 | 30 Sep 2014 | 10-K | 23 Feb 2016 | 2015 | FY | |
| Q2 2014 | $143,777,000 | $35,222,000 | -$2,467,000 | -7.5% | 01 Apr 2014 | 30 Jun 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q1 2014 | $141,310,000 | $41,295,000 | -$13,634,000 | -49% | 01 Jan 2014 | 31 Mar 2014 | 10-K | 23 Feb 2016 | 2015 | FY |
| Q4 2013 | $127,676,000 | $33,084,000 | +$14,042,000 | +30% | 01 Oct 2013 | 31 Dec 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q3 2013 | $141,718,000 | $34,176,000 | -$52,942,000 | -282% | 01 Jul 2013 | 30 Sep 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q2 2013 | $88,776,000 | $32,755,000 | -$18,468,000 | -129% | 01 Apr 2013 | 30 Jun 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q1 2013 | $70,308,000 | $27,661,000 | -$17,500,000 | -172% | 01 Jan 2013 | 31 Mar 2013 | 10-K | 24 Feb 2015 | 2014 | FY |
| Q4 2012 | $52,808,000 | $47,126,000 | -$33,514,000 | -246% | 01 Oct 2012 | 31 Dec 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q3 2012 | $19,294,000 | $18,766,000 | +$30,349,000 | 01 Jul 2012 | 30 Sep 2012 | 10-K | 25 Feb 2014 | 2013 | FY | |
| Q2 2012 | $49,643,000 | $14,287,000 | -$2,921,000 | -26% | 01 Apr 2012 | 30 Jun 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q1 2012 | $46,722,000 | $10,161,000 | -$8,194,000 | -417% | 01 Jan 2012 | 31 Mar 2012 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q4 2011 | $38,528,000 | $13,612,000 | 01 Oct 2011 | 31 Dec 2011 | 10-K | 05 Mar 2013 | 2012 | FY | ||
| Q3 2011 | $11,583,000 | +$9,668,087 | +45% | 01 Jul 2011 | 30 Sep 2011 | 10-K | 05 Mar 2013 | 2012 | FY | |
| Q2 2011 | $11,366,000 | -$5,833,035 | -105% | 01 Apr 2011 | 30 Jun 2011 | 10-K | 05 Mar 2013 | 2012 | FY | |
| Q1 2011 | $1,967,000 | 01 Jan 2011 | 31 Mar 2011 | 10-K | 05 Mar 2013 | 2012 | FY | |||
| Q3 2010 | $21,251,087 | 01 Jul 2010 | 30 Sep 2010 | 10-Q | 08 Nov 2011 | 2011 | Q3 | |||
| Q2 2010 | $5,532,965 | 01 Apr 2010 | 30 Jun 2010 | 10-Q | 09 Aug 2011 | 2011 | Q2 |
INFINITY PHARMACEUTICALS, INC. Annual Operating Income (Loss) (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | $44,844,000 | +$239,000 | +0.53% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2021 | $45,083,000 | -$6,586,000 | -17% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 28 Mar 2023 | 2022 | FY |
| 2020 | $38,497,000 | +$7,167,000 | +16% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 29 Mar 2022 | 2021 | FY |
| 2019 | $45,664,000 | -$33,735,000 | -283% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 16 Mar 2021 | 2020 | FY |
| 2018 | $11,929,000 | +$24,516,000 | +67% | 01 Jan 2018 | 31 Dec 2018 | 10-K | 03 Mar 2020 | 2019 | FY |
| 2017 | $36,445,000 | -$5,554,000 | -18% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 14 Mar 2019 | 2018 | FY |
| 2016 | $30,891,000 | +$96,217,000 | +76% | 01 Jan 2016 | 31 Dec 2016 | 10-K | 15 Mar 2018 | 2017 | FY |
| 2015 | $127,108,000 | -$119,185,000 | -1504% | 01 Jan 2015 | 31 Dec 2015 | 10-K | 15 Mar 2018 | 2017 | FY |
| 2014 | $7,923,000 | +$119,753,000 | +94% | 01 Jan 2014 | 31 Dec 2014 | 10-K | 14 Mar 2017 | 2016 | FY |
| 2013 | $127,676,000 | -$74,868,000 | -142% | 01 Jan 2013 | 31 Dec 2013 | 10-K | 23 Feb 2016 | 2015 | FY |
| 2012 | $52,808,000 | -$14,280,000 | -37% | 01 Jan 2012 | 31 Dec 2012 | 10-K | 24 Feb 2015 | 2014 | FY |
| 2011 | $38,528,000 | +$10,443,000 | +21% | 01 Jan 2011 | 31 Dec 2011 | 10-K | 25 Feb 2014 | 2013 | FY |
| 2010 | $48,971,000 | 01 Jan 2010 | 31 Dec 2010 | 10-K | 05 Mar 2013 | 2012 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.